ProThera Biologics Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 2

ProThera Biologics General Information

Description

Developer of integrated theranostic and therapeutic biomolecules designed to treat life-threatening inflammatory diseases. The company's biomolecules help control inflammation by modulating multiple pathways and play a role in tissue repair, enabling doctors to effectively treat diseases such as sepsis and cancer.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 349 Eddy Street
  • Providence, RI 02903
  • United States
+1 (401)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 349 Eddy Street
  • Providence, RI 02903
  • United States
+1 (401)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ProThera Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
19. Secondary Transaction - Private Completed Generating Revenue
18. Grant 19-Jun-2019 Completed Generating Revenue
17. Later Stage VC 04-Jan-2019 Completed Generating Revenue
16. Grant 15-Aug-2018 Completed Generating Revenue
15. Grant 15-Jun-2017 Completed Generating Revenue
14. Later Stage VC 26-Sep-2016 Completed Generating Revenue
13. Grant 17-Sep-2015 Completed Generating Revenue
12. Grant 01-Jan-2014 Completed Generating Revenue
11. Later Stage VC 05-Sep-2012 $250K $750K Completed Generating Revenue
10. Grant 01-Jan-2012 $498K $500K Completed Generating Revenue
To view ProThera Biologics’s complete valuation and funding history, request access »

ProThera Biologics Patents

ProThera Biologics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20230055086-A1 Inter-alpha inhibitor proteins Inactive 19-Aug-2021
AU-2021377336-A1 Methods for purifying inter-alpha inhibitor proteins Pending 16-Nov-2020
AU-2021377336-A9 Methods for purifying inter-alpha inhibitor proteins Pending 16-Nov-2020
CA-3198925-A1 Methods for purifying inter-alpha inhibitor proteins Pending 16-Nov-2020
EP-4244629-A1 Methods for purifying inter-alpha inhibitor proteins Pending 16-Nov-2020 G01N33/6893
To view ProThera Biologics’s complete patent history, request access »

ProThera Biologics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ProThera Biologics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds
Liminal R and D BioSciences Corporation
National Institute for Allergy and Infectious Disease Government
To view ProThera Biologics’s complete investors history, request access »

ProThera Biologics FAQs

  • When was ProThera Biologics founded?

    ProThera Biologics was founded in 2001.

  • Where is ProThera Biologics headquartered?

    ProThera Biologics is headquartered in Providence, RI.

  • What is the size of ProThera Biologics?

    ProThera Biologics has 6 total employees.

  • What industry is ProThera Biologics in?

    ProThera Biologics’s primary industry is Drug Discovery.

  • Is ProThera Biologics a private or public company?

    ProThera Biologics is a Private company.

  • What is ProThera Biologics’s current revenue?

    The current revenue for ProThera Biologics is .

  • How much funding has ProThera Biologics raised over time?

    ProThera Biologics has raised $2.75M.

  • Who are ProThera Biologics’s investors?

    Liminal R and D BioSciences and National Institute for Allergy and Infectious Disease have invested in ProThera Biologics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process